Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab209766-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$109.90
|
|
|
Ab209766-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$509.90
|
|
|
Ab209766-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,399.90
|
|
|
Ab209766-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,299.90
|
|
Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level< 0.01EU/μg; Human IgG2SA; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
| Product Name | Amgen patent anti-ORAI1 (anti-ORAI1) - Primary antibody, specific to ORAI1, Human IgG2SA |
|---|---|
| Synonyms | Calcium release activated calcium channel protein 1 antibody | Calcium release activated calcium modulator 1 antibody | Calcium release-activated calcium channel protein 1 antibody | CRACM 1 antibody | CRACM1 antibody | CRCM1 antibody | CRCM1_HUMAN antibo |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Biochemical and Physiological Mechanisms | Ca(2+) release-activated Ca(2+) (CRAC) channel subunit which mediates Ca(2+) influx following depletion of intracellular Ca(2+) stores and channel activation by the Ca(2+) sensor, STIM1. CRAC channels are the main pathway for Ca(2+) influx in T-cells and |
| Host species | Human |
| Specificity | ORAI1 |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Product Description |
Amgen patent anti-ORAI1 (anti-ORAI1) is a human monoclonal anti-Orai1 antibody (mAb) with the potential to treat autoimmune diseases. |
| Isotype | Human IgG2SA |
|---|---|
| Light Chain Type | lambdaC2 |
| SDS-PAGE | 150 kDa |
| Purification Method | Protein A purified |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Amgen patent anti-ORAI1 (anti-ORAI1) (Ab209766) - Flow Cytometry
Flow Cytometry analysis of pLVX_Hu_TAM2/ORAI1 cells labelling ORAI1 at 1×105 cell/well can bind Amgen patent anti-ORAI1 (anti-ORAI1) (Ab209766), with the EC50 is 1.529 μg/mL.
Amgen patent anti-ORAI1 (anti-ORAI1) (Ab209766) - SEC
The purity of Amgen patent anti-ORAI1 (anti-ORAI1) (Ab209766) is more than 95% verified by HPLC.